The activating enzymes of vitamin d metabolism (25- and 1α-hydroxylases)

Vitamin D

Volumn , Issue , 2011, Pages 23-42

  Jones, Glenville ^a   Prosser, David E ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884788411     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381978-9.10003-4     Document Type: Chapter

References (142)

1. DeLuca H.F. Vitamin D: the vitamin and the hormone. Fed. Proc. 1974, 33:2211-2219.
2. Ponchon G., DeLuca H.F. The role of the liver in the metabolism of vitamin D. J. Clin. Invest. 1969, 48:1273-1279.
3. Fraser D.R., Kodicek E. Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature 1970, 228:764-766.
4. Hewison M., Adams J. Chapter 79: Extra-renal 1α-hydroxylase activity and human disease. Vitamin D 2005, 1379-1403. Academic Press, San Diego CA. second ed. D. Feldman, W. Pike, F. Glorieux (Eds.).
5. Cheng J.B., Levine M.A., Bell N.H., Mangelsdorf D.J., Russell D.W. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc. Natl. Acad. Sci. USA 2004, 101:7711-7715.
6. St-Arnaud R., Messerlian S., Moir J.M., Omdahl J.L., Glorieux F.H. The 25-hydroxyvitamin D 1-α-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J. Bone Miner. Res. 1997, 12:1552-1559.
7. Takeyama K., Kitanaka S., Sato T., Kobori M., Yanagisawa J., Kato S. 25-Hydroxyvitamin D3 1α-hydroxylase and vitamin D synthesis. Science 1997, 277:1827-1830.
8. Nelson D.R. The cytochrome p450 homepage. Hum. Genomics 2009, 4:59-65.
9. Gascon-Barre M. Chapter 4: The vitamin D 25-hydroxylase. Vitamin D 2005, 47-69. Academic Press, San Diego CA. second ed. D. Feldman, W. Pike, F. Glorieux (Eds.).
10. Henry H.L. Chapter 5: The 25-Hydroxyvitamin D 1α-hydroxylase. Vitamin D 2005, 69-85. Academic Press, San Diego CA. second ed. D. Feldman, W. Pike, F. Glorieux (Eds.).
11. Jones G., Strugnell S., DeLuca H.F. Current understanding of the molecular actions of vitamin D. Physiol. Rev. 1998, 78:1193-1231.
12. Whitfield G.K., Jurutka P.W., Haussler C., Hsieh J.-C., Barthel T., Jacobs E.T., et al. Chapter 13: Nuclear Receptor: Structure-Function, Molecular Control of gene Transcription and Novel Bioactions. Vitamin D 2005, 219-262. Academic Press, San Diego CA. second ed. D. Feldman, J.W. Pike, F.H. Glorieux (Eds.).
13. Prosser D.E., Guo Y.-D., Jia Z., Jones G. Molecular modelling of CYP27A1 and site-directed mutational analyses affecting vitamin D hydroxylation. Biophys. J. 2006, 90:3389-3409.
14. Hamamoto H., Kusudo T., Urushino N., Masuno H., Yamamoto K., Yamada S., Kamakura M., Ohta M., Inouye K., Sakaki T. Structure-function analysis of vitamin D 24-hydroxylase (CYP24A1) by site-directed mutagenesis: amino acid residues responsible for species-based difference of CYP24A1 between humans and rats. Mol. Pharmacol. 2006, 70:120-128.
15. Masuda S., Prosser D.E., Guo Y.D., Kaufmann M., Jones G. Generation of a homology model for the human cytochrome P450, CYP24A1, and the testing of putative substrate binding residues by site-directed mutagenesis and enzyme activity studies. Arch. Biochem. Biophys. 2007, 460:177-191.
16. 3-26,23-lactone. Proc. Natl. Acad. Sci. USA 2007, 104:12673-12678.
17. Annalora A.J., Bobrovnikov-Marjon E., Serda R., Pastuszyn A., Graham S.E., Marcus C.B., Omdahl J.L. Hybrid homology modeling and mutational analysis of cytochrome P450C24A1 (CYP24A1) of the Vitamin D pathway: insights into substrate specificity and membrane bound structure-function. Arch. Biochem. Biophys. 2007, 460:262-273.
18. 3. J. Mol. Biol. 2008, 380:95-106.
19. Annalora A.J., Goodin D.B., Hong W.X., Zhang Q., Johnson E.F., Stout C.D. Crystal structure of CYP24A1, a mitochondrial cytochrome P450 involved in vitamin D metabolism. J. Mol. Biol. 2010, 396:441-451.
20. Bhattacharyya M.H., DeLuca H.F. The regulation of rat liver calciferol-25-hydroxylase. J. Biol. Chem. 1973, 248:2969-2973.
21. Bhattacharyya M.H., DeLuca H.F. Subcellular location of rat liver calciferol-25-hydroxylase. Arch. Biochem. Biophys. 1974, 160:58-62.
22. Fukushima M., Nishil Y., Suzuki M., Suda T. Comparative studies on the 25-hydroxylations of cholecalciferol and 1 alpha-hydroxycholecalfierol in perfused rat liver. Biochem. J. 1978, 170:495-502.
23. Cheng J.B., Motola D.L., Mangelsdorf D.J., Russell D.W. De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxylase. J. Biol. Chem. 2003, 278:38084-38093.
24. Nelson D.R. Comparison of P450s from human and fugus: 420 million years of vertebrate P450 evolution. Arch. Biochem. Biophys. 2003, 409:18-24.
25. Jones G., Byford V., West S., Masuda S., Ibrahim G., Kaufmann M., Knutson J., Strugnell S., Mehta R. Hepatic Activation & Inactivation of Clinically-Relevant Vitamin D Analogs and Prodrugs. Anticancer Res. 2006, 26:2589-2596.
26. Casella S.J., Reiner B.J., Chen T.C., Holick M.F., Harrison H.E. A possible genetic defect in 25-hydroxylation as a cause of rickets. J. Pediatr. 1994, 124:929-932.
27. Fraser D., Kooh S.W., Kind H.P., Holick M.F., Tanaka Y., DeLuca H.F. Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1α,25-dihydroxyvitamin D. N. Engl. J. Med. 1973, 289:817-822.
28. Thacher T.D., Fischer P.R., Pettifor J.M., Lawson J.O., Isichei C.O., Chan G.M. Case-control study of factors associated with nutritional rickets in Nigerian children. J. Pediatr. 2000, 137:367-373.
29. Wang T.J., Zhang F., Richards J.B., Kestenbaum B., van Meurs J.B., Berry D., et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010, 376:180-188.
30. Cali J.J., Russell D.W. Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. J. Biol. Chem. 1991, 266:7774-7778.
31. Strugnell S., Guo Y.D., Back D.W., Jones G. Transfected human liver cytochrome P-450 hydroxylases vitamin D analogs at different side chain positions. Proc. Natl. Acad. Sci. USA 1993, 90:8668-8672.
32. Ohyama Y., Masumoto O., Usui E., Okuda K. Multi-functional property of rat liver mitochondrial cytochrome P-450. J. Biochem. 1991, 109:389-393.
33. 2 made in the human hepatoma, Hep3B. Biochem. J. 1995, 310:233-241.
34. Pikuleva I.A., Björkhem I., Waterman M.R. Expression, purification, and enzymatic properties of recombinant human cytochrome P450c27 (CYP27). Arch. Biochem. Biophys. 1997, 343:123-130.
35. Mast N., Murtazina D., Liu H., Graham S.E., Bjorkhem I., Halpert J.R., Peterson J., Pikuleva I.A. Distinct binding of cholesterol and 5β-cholestane-3α,7α,12α-triol to cytochrome P450 27A1: evidence from modeling and site-directed mutagenesis studies. Biochemistry 2006, 45:4396-4404.
36. Repa J.J., Lund E.G., Horton J.D., Leitersdorf E., Russell D.W., Dietschy J.M., Turley S.D. Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hyper-triglyceridemia. Reversal by cholic acid feeding. J. Biol. Chem. 2000, 275:39685-39692.
37. Cali J.J., Hsieh C.L., Francke U., Russell D.W. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J. Biol. Chem. 1991, 266:7779-7783.
38. Berginer V.M., Shany S., Alkalay D., Berginer J., Dekel S., Salen G., Tint G.S., Gazit D. Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis. Metabolism 1993, 42:69-74.
39. Björkhem I., Hansson M. Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge. Biochem. Biophys. Res. Commun. 2010, 396:46-49.
40. Jones G. Vitamin D analogs. In: Vitamin D for Endocrinology and Metabolism. Ed: Sol Epstein. Endocrinol. Metab. Clin. North. Am. 2010, 39:447-472.
41. 2. Arch. Biochem. Biophys. 1980, 202:450-457.
42. 2 in mammals. Biochemistry 1990, 29:578-582.
43. Gupta R.P., Hollis B.W., Patel S.B., Patrick K.S., Bell N.H. CYP3A4 is a human microsomal vitamin D 25-hydroxylase. J. Bone Miner. Res. 2004, 19:680-688.
44. Gupta R.P., He Y.A., Patrick K.S., Halpert J.R., Bell N.H. CYP3A4 is a vitamin D-24- and 25-hydroxylase: analysis of structure function by site-directed mutagenesis. J. Clin. Endocrinol. Metab. 2005, 90:1210-1219.
45. 3: implications for drug-induced osteomalacia. Mol. Pharmacol. 2006, 69:56-65.
46. 3. Mol. Pharmacol. 2001, 60:1399-1406.
47. Thompson P.D., Jurutka P.W., Whitfield G.K., Myskowski S.M., Eichhorst K.R., Dominguez C.E., et al. Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements. Biochem. Biophys. Res. Commun. 2002, 299:730-738.
48. 2 and calcitriol effects in an adenine-induced model of CKD reveals differential control over serum calcium and phosphate. J. Bone Min. Res. 2008, 23:S357. Abs SU448.
49. G. Jones, V. Byford, C. Helvig, M. Petkovich, Differential disposition of vitamin D2 does not involve CYP24A1. Presented at 14th International Vitamin D Workshop, Brugge, Belgium, 2009 October 4-8 2009.
50. 3 on bone metabolism in patients treated with phenobarbitone/phenytoin. Calcif. Tissue. Int. 1985, 37:218-222.
51. 3 25-hydroxylase expression: a potential new mechanism for drug-induced osteomalacia. Biochem. Biophys. Res. Commun. 2007, 357:603-607.
52. Holick M.F., Schnoes H.K., DeLuca H.F., Suda T., Cousins R.J. Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochemistry 1971, 10:2799-2804.
53. Omdahl J.L., Gray R.W., Boyle I.T., Knutson J., DeLuca H.F. Regulation of metabolism of 25-hydroxycholecalciferol by kidney tissue in vitro by dietary calcium. Nat. New Biol. 1972, 237:63-64.
54. Tanaka Y., DeLuca H.F. The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus. Arch. Biochem. Biophys. 1973, 154:566-574.
55. Gray R.W., Omdahl J.L., Ghazarian J.G., DeLuca H.F. 25-Hydroxycholecalciferol-1-hydroxylase. Subcellular location and properties. J. Biol. Chem. 1972, 247:7528-7532.
56. Akiba T., Endou H., Koseki C., Sakai F., Horiuchi N., Suda T. Localization of 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase activity in the mammalian kidney. Biochem. Biophys. Res. Commun. 1980, 94:313-318.
57. Kawashima H., Kurokawa K. Unique hormonal regulation of vitamin D metabolism in the mammalian kidney. Miner. Electrolyte Metab. 1983, 9:227-235.
58. 3-1α-hydroxylase in the proximal straight tubule of the rat kidney. Nature 1981, 291:327-329.
59. 3-1α-hydroxylase gene in normocalcemic rats. Proc. Nat. Acad. Sci. USA 1999, 96:8253-8258.
60. Ghazarian J.G., Jefcoate C.R., Knutson J.C., Orme-Johnson W.H., DeLuca H.F. Mitochondrial cytochrome p450. A component of chick kidney 25-hydrocholecalciferol-1α-hydroxylase. J. Biol. Chem. 1974, 249:3026-3033.
61. Weisman Y., Vargas A., Duckett G., Reiter E., Root A.W. Synthesis of 1,25-dihydroxyvitamin D in the nephrectomized pregnant rat. Endocrinology 1978, 103:1992-1996.
62. 3 in pregnancy. Science 1979, 204:1311-1313.
63. 3. J. Biol. Chem. 1981, 256:7738-7740.
64. 3-1α hydroxylase expression and activity in cultured human osteoblasts and their modulation by parathyroid hormone, estrogenic compounds and dihydrotestosterone. J. Steroid Biochem. Mol. Biol. 2007, 107:238-244.
65. 3 in vitro. Biochem. Biophys. Res. Commun. 1982, 109:723-729.
66. 3 by cultured pulmonary alveolar macrophages in sarcoidosis. J. Clin. Invest. 1983, 72:1856-1860.
67. St-Arnaud R., Messerlian S., Moir J.M., Omdahl J.L., Glorieux F.H. The 25-hydroxyvitamin D-1α-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J. Bone Miner. Res. 1997, 12:1552-1559.
68. Takeyama K., Kitanaka S., Sato T., Kobori M., Yanagisawa J., Kato S. 25-Hydroxyvitamin D3 1α-hydroxylase and vitamin D synthesis. Science 1997, 277:1827-1830.
69. 3 1α-hydroxylase. Biochem. Biophys. Res. Commun. 1997, 239:527-533.
70. Fu G.K., Lin D., Zhang M.Y.H., Bikle D.D., Shackleton C.H.L., Miller W.L., et al. Cloning of human 25-hydroxyvitamin D-1α-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Molec. Endocr. 1997, 11:1961-1970.
71. Jones G., Ramshaw H., Zhang A., Cook R., Byford V., White J., et al. Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1α and CYP24) in human non-small cell lung carcinomas. Endocrinology 1999, 140:3303-3310.
72. Zehnder D., Bland R., Williams M.C., McNinch R.W., Howie A.J., Stewart P.M., et al. Extrarenal expression of 25-hydroxyvitamin D3-1α-hydroxylase. J. Clin. Endocr. Metab. 2001, 86:888-894.
73. Scriver C.R., Reade T.M., DeLuca H.F., Hamstra A.J. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease. N. Engl. J. Med. 1978, 299:976-979.
74. Miller W.L., Portale A.A. Vitamin D 1α-hydroxylase, Trends. Endocrinol. Metab. 2000, 11:315-319.
75. Kitanaka S., Takeyama K., Murayama A., Kato S. The molecular basis of vitamin D-dependent rickets type I. Endocr. J. 2001, 48:427-432.
76. Wang X., Zhang M.Y., Miller W.L., Portale A.A. Novel gene mutations in patients with 1α-hydroxylase deficiency that confer partial enzyme activity in vitro. J. Clin. Endocrinol. Metab. 2002, 87:2424-2430.
77. Kim C.J., Kaplan L.E., Perwad F., Huang N., Sharma A., Choi Y., et al. Vitamin D 1α-hydroxylase gene mutations in patients with 1α-hydroxylase deficiency. J. Clin. Endocr. Metab. 2007, 92:3177-3182.
78. Malloy P., Feldman D. Genetic Disorders and Defects in Vitamin D action. In: Vitamin D for Endocrinology and Metabolism. Ed: Sol Epstein. Endocrinol. Metab. Clin. North Am. 2010, 39:333-346.
79. Panda D.K., Miao D., Tremblay M.L., Sirois J., Farookhi R., Hendy G.N., et al. Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc. Nat. Acad. Sci. USA 2001, 98:7498-7503.
80. Dardenne O., Prud'homme J., Arabian A., Glorieux F.H., St-Arnaud R. Targeted inactivation of the 25-hydroxyvitamin D3-1α-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 2001, 142:3135-3141.
81. 3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development. Hum. Molec. Genet. 2005, 14:1515-1528.
82. Bikle D.D., Chang S., Crumrine D., Elalieh H., Man M.Q., Choi E.H., et al. 25 Hydroxyvitamin D 1 α-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. J. Invest. Dermatol. 2004 Apr, 122(4):984-992.
83. 2+ and 1,25-dihydroxyvitamin D3 in 25-hydroxyvitamin D3-1α-hydroxylase knockout mice. FASEB J. 2002, 16:1398-1406.
84. 3: biochemical, histomorphometric, and biomechanical analyses. J. Bone. Miner. Res. 2003, 18:637-644. 3.
85. Dardenne O., Prud'homme J., Hacking S.A., Glorieux F.H., St-Arnaud R. Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1α-hydroxylase (CYP27B1). Bone 2003, 32:332-340.
86. 3-1α-hydroxylase promoter activity in the skin. Proc. Nat. Acad. Sci. USA 2006, 103:75-80.
87. St-Arnaud R., Dardenne O., Prud'homme J., Hacking S.A., Glorieux F.H. Conventional and tissue-specific inactivation of the 25-hydroxyvitamin D-1α-hydroxylase (CYP27B1). J. Cell. Biochem. 2003, 88:245-251.
88. Naja R.P., Dardenne O., Arabian A., St Arnaud R. Chondrocyte-specific modulation of Cyp27b1 expression supports a role for local synthesis of 1,25-dihydroxyvitamin D3 in growth plate development. Endocrinology 2009, 150:4024-4032.
89. 3 1α-hydroxylase gene transcription product in cultures of human syncytiotrophoblast cells. J. Clin. Endocr. Metab. 2000, 85:2543-2549.
90. Whitlatch L.W., Young M.V., Schwartz G.G., Flanagan J.N., Burnstein K.L., Lokeshwar B.L., et al. 25-Hydroxyvitamin D-1α-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. J. Steroid. Biochem. Mol. Biol. 2002, 81:135-140.
91. Tangpricha V., Flanagan J.N., Whitlatch L.W., Tseng C.C., Chen T.C., Holt P.R., et al. 25-Hydroxyvitamin D-1α-hydroxylase in normal and malignant colon tissue. Lancet 2001, 357:1673-1674.
92. Bareis P., Bises G., Bischof M.G., Cross H.S., Peterlik M. 25-hydroxy-vitamin D metabolism in human colon cancer cells during tumor progression. Biochem. Biophys. Res. Commun. 2001, 285:1012-1017.
93. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357:266-281.
94. 3. Seminars in Dialysis 2007, 20:316-324.
95. Adams J.S., Hewison M. Update in vitamin D. J. Clin. Endocrinol. Metab. 2010, 95:471-478.
96. Martinez I., Saracho R., Montenegro J., Llach F. A deficit of calcitriol synthesis may not be the initial factor in the pathogenesis of secondary hyperparathyroidism. Nephrol. Dial. Transplant. 1996, 11(Suppl. 3):22-28.
97. Inoue Y., Segawa H., Kaneko I., Yamanaka S., Kusano K., Kawakami E., et al. Role of the vitamin D receptor in FGF23 action on phosphate metabolism. Biochem. J. 2005, 390:325-331.
98. Olauson H., Qureshi A.R., Miyamoto T., Barany P., Heimburger O., Lindholm B., et al. Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?. Nephrol. Dial. Transplant. 2010, 25:3033-3038.
99. 3-1α-hydroxylase gene promoter. Proc. Nat. Acad. Sci. USA 1998, 95:1387-1391.
100. 3. Biochem. Biophys. Res. Commun. 1998, 249:11-16.
101. Liu S., Quarles L.D. How fibroblast growth factor 23 works. J. Am. Soc. Nephrol. 2007, 18:1637-1647.
102. 3-1α-hydroxylase gene. Proc. Nat. Acad. Sci. USA 1999, 96:6988-6993. 1999.
103. 3-induced DNA methylation suppresses the human CYP27B1 gene. Molec. Cell Endocr. 2007, 265-266:168-173.
104. Kim M.-S., Kondo T., Takada I., Youn M.-Y., Yamamoto Y., Takahashi S., et al. DNA demethylation in hormone-induced transcriptional derepression. Nature 2009, 461:1007-1012.
105. 3 metabolism by isolated perfused rat kidney. Am. J. Physiol. 1980, 239:E12-E20.
106. Adams J.S., Singer F.R., Gacad M.A., Sharma O.P., Hayes M.J., Vouros P., et al. Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. J. Clin. Endocrinol. Metab. 1985, 60:960-966.
107. Esteban L., Vidal M., Dusso A. 1α-Hydroxylase transactivation by gamma-interferon in murine macrophages requires enhanced C/EBPbeta expression and activation. J. Steroid Biochem. Mol. Biol. 2004, 89-90:131-137.
108. Overbergh L., Stoffels K., Waer M., Verstuyf A., Bouillon R., Mathieu C. Immune regulation of 25-hydroxyvitamin D-1α-hydroxylase in human monocytic THP1 cells: mechanisms of interferon-γ-mediated induction. J. Clin. Endocrinol. Metab. 2006, 91:3566-3574.
109. Wu S., Ren S., Nguyen L., Adams J.S., Hewison M. Splice variants of the CYP27b1 gene and the regulation of 1,25-dihydroxyvitamin D3 production. Endocrinology 2007, 148:3410-3418.
110. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
111. Schauber J., Dorschner R.A., Coda A.B., Buchau A.S., Liu P.T., Kiken D., et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 2007, 117:803-881.
112. Stubbs J.R., Idiculla A., Slusser J., Menard R., Quarles L.D. Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD. J. Am. Soc. Nephrol. 2010, 21:353-361.
113. Prosser D.E., Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem. Sci. 2004, 29:664-673.
114. 3. Biochemistry 2008, 47:4017-4027.
115. Yasutake Y., Fujii Y., Cheon W.K., Arisawa A., Tamura T. Crystallization and preliminary X-ray diffraction studies of vitamin D3 hydroxylase, a novel cytochrome P450 isolated from Pseudonocardia autotrophica. Acta. Crystallogr. Sect. F. Struct. Biol. Cryst. Commun. 65 IS. - Pt. 2009, 4:372-375.
116. Cojocaru V., Winn P.J., Wade R.C. The ins and outs of cytochrome P450s. Biochim. Biophys. Acta - General. Subjects 2007, 1770:390-401.
117. 3 whose mutation causes vitamin D-dependent rickets type 1. J. Biol. Chem. 2005, 280:30511-30516.
118. Annalora A., Bobrovnikova-Marjon E., Serda R., Lansing L., Chiu M.L., Pastuszyn A., et al. Rat cytochrome P450C24 (CYP24A1) and the role of F249 in substrate binding and catalytic activity. Arch. Biochem. Biophys. 2004, 425:133-146.
119. Schuster I., Egger H., Bikle D., Herzig G., Reddy G.S., Stuetz A., et al. Selective inhibition of vitamin D hydroxylases in human keratinocytes. Steroids 2001, 66:409-422.
120. Schuster I., Egger H., Nussbaumer P., Kroemer R.T. Inhibitors of vitamin D hydroxylases: structure-activity relationships. J. Cell Biochem. 2003, 88:372-380.
121. Schuster I. 2010 Cytochromes P450 are essential players in the vitamin D signaling system. Biochim. Biophys. Acta 2010, 1814:186-199.
122. 3 autoregulation in keratinocytes. J. Biol. Chem. 2002, 277:36987-36990.
123. 3. J. Steroid Biochem. Mol. Biol. 2004, 89-90:5-12.
124. Posner G.H., Helvig C., Cuerrier D., Collop D., Kharebov A., Ryder K., et al. Vitamin D analogues targeting CYP24 in chronic kidney disease. J. Steroid Biochem. Mol. Biol. 2010, 121:13-19.
125. 3 plasma levels in type 1 diabetes patients. J. Steroid Biochem. Mol. Biol. 2010, In press.
126. 2 metabolite, inhibits growth of breast cancer cells and tumors. Anticancer Res. 2005, 25:235-241.
127. Nozue T., Higashikata T., Inazu A., Kawashiri M.A., Nohara A., Kobayashi J., et al. Identification of a novel missense mutation in the sterol 27-hydroxylase gene in two Japanese patients with cerebrotendinous xanthomatosis. Intern. Med. 2010, 49:1127-1131.
128. Gallus G.N., Dotti M.T., Mignarri A., Rufa A., Da Pozzo P., Cardaioli E., et al. Four novel CYP27A1 mutations in seven Italian patients with CTX. Eur. J. Neurol. 2010, 17:1259-1262.
129. Lamon-Fava S., Schaefer E.J., Garuti R., Salen G., Calandra S. Two novel mutations in the sterol 27-hydroxylase gene causing cerebrotendinous xanthomatosis. Clin. Genet. 2002, 61:185-191.
130. Castelnovo G., Jomir L., Bouly S. Cerebrotendinous xanthomatosis. J. Neurol. Neurosurg. Psychiatry 2003, 74:1335.
131. Alzahrani A.S., Zou M., Baitei E.Y., Alshaikh O.M., Al-Rijjal R.A., Meyer B.F., et al. A Novel G102E Mutation of CYP27B1 in a Large Family with Vitamin D-Dependent Rickets Type 1. J. Clin. Endocrinol. Metab. 2010, 95:4176-4183.
132. Shinkyo R., Sakaki T., Kamakura M., Ohta M., Inouye K. Metabolism of vitamin D by human microsomal CYP2R1. Biochem. Biophys. Res. Commun. 2004, 324:451-457.
133. 3 25-hydroxylase. J. Biol. Chem. 2004, 279:22848-22856.
134. Choudhary D., Jansson I., Stoilov I., Sarfarazi M., Schenkman J.B. Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues. Arch. Biochem. Biophys. 2005, 436:50-61.
135. Rahmaniyan M., Patrick K.S., Bell N.H. Characterization of recombinant CYP2C11: a vitamin D 25-hydroxylase and 24-hydroxylase. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E753-E760.
136. 3 in primary cultures of pig hepatocytes: evidence for a role of both CYP2D25 and CYP27A1. Biochem. Biophys. Res. Commun. 2003, 303:877-883.
137. Aiba I., Yamasaki T., Shinki T., Izumi S., Yamamoto K., Yamada S., et al. Characterization of rat and human CYP2J enzymes as Vitamin D 25-hydroxylases. Steroids 2006, 71:849-856.
138. Inoue K., Inazawa J., Nakagawa H., Shimada T., Yamazaki H., Guengerich F.P., et al. Assignment of the human cytochrome P-450 nifedipine oxidase gene (CYP3A4) to chromosome 7 at band q22.1 by fluorescence in situ hybridization. Jpn. J. Hum. Genet. 1992, 37:133-138.
139. Fu G.K., Portale A.A., Miller W.L. Complete structure of the human gene for the vitamin D 1α-hydroxylase, P450c1. DNA. Cell Biol. 1997, 16:1499-1507.
140. 450 subunit maps to a different chromosomal location than that of pseudovitamin D-deficient rickets. J. Bone Miner. Res. 1993, 8:1397-1406.
141. 3 24-hydroxylase cDNA. Proc. Natl. Acad. Sci. USA 1993, 90:4543-4547.
142. 3 24-hydroxylase. FEBS Lett. 1991, 278:195-198.